Institutional Sign In

Go

Expenditure on Pharmaceuticals Per Capita, PPP (USD) rose 6.35% to USD 430 in Netherlands in 2019

Expenditure on Pharmaceuticals Per Capita, PPP (USD) (USD), 2019
Pharmaceutical | Netherlands | September 2, 2020
$2.99
Excel Sheet

Expenditure on pharmaceuticals per capita in PPP prices rose 6.35% to USD 430 in Netherlands in 2019, according to OECD.

Historically, expenditure on pharmaceuticals per capita in PPP prices in Netherlands reached an all time high of USD 444 in 2007 and an all time low of USD 36.0 in 1972.

Netherlands has been ranked 6th within the group of 6 countries we follow in terms of expenditure on pharmaceuticals per capita in PPP prices, 17 places above the position seen 10 years ago.

Expenditure on Pharmaceuticals Per Capita, PPP (USD) Unit 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Austria USD 567 590 608 622 647 ...
Belgium USD ... ... ... ... 629 632 668 685 710 ...
Denmark USD 309 311 317 320 323 ...
France USD 637 648 638 660 667 ...
Germany USD 692 738 759 817 855 ...
Ireland USD 582 555 561 591 610 ...
Luxembourg USD 566 551 548 564 573 ...
Netherlands USD 378 371 381 393 401
Norway USD 416 427 440 447 464
Poland USD ... ... ... 363 362 386 411 422 ...
Sweden USD 475 487 504 523 521 ...
United Kingdom USD ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 468 476 481 493